Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Return on Tangible Equity data is not available.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$12.01M |
|
$0.25M |
|
$7.79M |
|
$19.80M |
|
$3.31M |
|
-- |
|
$1.21M |
|
$4.53M |
|
$15.27M |
|
$7.73M |
|
$15.27M |
|
0.62M |
|
| Cash Flow Statement Financials | |
$-4.41M |
|
$-0.45M |
|
$8.03M |
|
$2.23M |
|
$5.39M |
|
$3.16M |
|
$0.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Tangible Equity |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|